Jul 10 |
Context Therapeutics acquires phase 1-ready T cell engager CT-95
|
Jul 10 |
Context Therapeutics Acquires Phase 1-ready T cell Engager CT-95
|
Jun 12 |
Is CareCloud (CCLD) Stock Outpacing Its Medical Peers This Year?
|
May 20 |
Are You Looking for a Top Momentum Pick? Why Context Therapeutics Inc. (CNTX) is a Great Choice
|
May 14 |
Context Therapeutics Inc. (CNTX) Upgraded to Buy: Here's Why
|
May 9 |
Context Therapeutics GAAP EPS of -$0.23
|
May 2 |
Context Therapeutics stock jumps on $100M private placement
|
May 2 |
Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM-76
|
May 2 |
Context Therapeutics Announces $100 Million Private Placement
|
Apr 1 |
Context Therapeutics rises on submission of IND application for its Claudin 6-positive cancers treatment
|